Zoekresultaten - 4 results
Annual Report Belgian Cystic Fibrosis Registry 2018
Pseudomonas aeruginosa reported in 2018 was 37.9%. This is in line with the general decline observed from 42.4% in 2012 to 37.5% in 2016. There has also been a steady increase in the prevalence of Achromobacter ...
Annual Report Belgian Cystic Fibrosis Registry 2017
increased since the decline observed from 42.4% in 2012 to 37.5% in 2016. There has also been a steady increase in the prevalence of Achromobacter xylosoxidans from 5.9% in 2009, stabilizing at prevalence ...
Risk factors and impact of allergic bronchopulmonary aspergillosis in Pseudomonas aeruginosa-negative CF patients.
a facilitating factor for ABPA. ABPA causes a significant increase in bronchial damage. In patients with ABPA, further bronchial damage can be controlled by an increase in hospitalization days and use of IV ...
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.
the non-transplanted cohort, 39.5% of patients with ppFEV1<40% were hospitalised with oxygen verses 3.2% with ppFEV >70%: a 17-fold increase in odds. Worse outcomes were independently associated ...